Veradigm Inc. (MDRX)
| Previous close | 9.65 |
| Open | 9.65 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 1000 |
| Day's range | 9.65 - 9.70 |
| 52-week range | 5.01 - 14.09 |
| Volume | |
| Avg. volume | 423,001 |
| Market cap | 1.044B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 11.28 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 07 Oct 2008 |
| 1y target est | N/A |
- Business Wire
Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024
CHICAGO, June 12, 2024--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payer Analytics the overall number one provider of payer analytics solutions for health plans.
- Business Wire
Veradigm Payerpath Rated Highest in Client Satisfaction
CHICAGO, May 30, 2024--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one provider of claims and clearinghouse platform solutions for small medical practices.
- Business Wire
Veradigm Announces Leadership Updates
CHICAGO, May 28, 2024--Veradigm Inc. (OTCMKTS: MDRX, the "Company"), a leading provider of healthcare data and technology solutions, today announced that, on June 7, 2024, Tom Langan, the Company’s President and Chief Commercial Officer (CCO), will assume the role of interim Chief Executive Officer (CEO), reporting directly to the Executive Chairman and the Board. Mr. Langan has been a Company leader since 2018 and has more than 25 years of life sciences, payer and data & analytics experience. I
